U.S. Court of Appeals for the Federal Circuit
Novartis Pharmaceuticals v. Accord Healthcare Inc.
This writing
- Type
- Opinion
- Author
- Richard Linn
- Filed
- June 21, 2022
- Case
- Novartis Pharmaceuticals v. Accord Healthcare Inc.
- Case status
- Decided
Source The authoring judge was read from the signature line of the court's own published opinion, not from provider metadata — CourtListener records no author for most Sixth Circuit opinions.
Opening text
The first passage of the document, as extracted by the source provider.
Case: 21-1070 Document: 51 Page: 1 Filed: 06/21/2022 United States Court of Appeals for the Federal Circuit ______________________ NOVARTIS PHARMACEUTICALS CORPORATION, Plaintiff-Appellee v. ACCORD HEALTHCARE, INC., AUROBINDO PHARMA LTD., AUROBINDO PHARMA USA, INC., DR. REDDY’S LABORATORIES, INC., DR. REDDY’S LABORATORIES, LTD., EMCURE PHARMACEUTICALS LTD., HERITAGE PHARMACEUTICALS INC.,…
Source Extract supplied by CourtListener. Benchlight does not host the document — read the authoritative text in the court's own PDF.